Surprisingly, the overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 individually and collectively were found as indicators of poor prognosis in non-small cell lung cancer, with PHD2 as the most significant prognostic marker [21]. Here, EGLN3 is linked to non-small cell lung carcinoma.